
HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%
E Sincerus Florida. LLC. Adverse reactions s Active, inactive x NDC 72934-2093-2 HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%. Cream 30gm v.
E Sincerus Florida. LLC. Adverse reactions s Active, inactive x NDC 72934-2093-2 HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%. Cream 30gm v.
Fd SIncerus Florida. LLC. Adverse reactions we Active, inactive xz HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%. Cream 30 gm sdf.
Dd Sincerus Florida. LLC. Adverse reactions sd Active, inactive sd NDC 72934- 6095-2 HYALURONIC ACID SODIUM SALT 1% / HYDROQUINONE USP 6%. Emulsion 30 gm asd.
D Sincerus Florida. LLC adverse reactions z Active, inactive z NDC 72934-2096-2 HYALURONIC ACID SODIUM SALT 1% / NIACINAMIDE 4% / TACROLIMUS 0.1% Cream 30 gm x.
Z Sincerus Florida. LLC. Adverse reactions x Active, inactive ad NDC 72934- 2097-2 HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS USP 0.1% / UREA USP 20%. Cream 30gm sxf.
As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2023. All Rights Reserved.